Damning study of over a million kids finds myocarditis only in the vaccinated



Biden administration officials and so-called experts characterized COVID-19 vaccines as "safe and effective" during the pandemic. In the face of an avalanche of tragic evidence to the contrary, the powers that be waged costly and unsuccessful propaganda and censorship campaigns to cure Americans' skepticism.

Although the Trump administration has alternatively acknowledged the risks and fallout associated with the vaccines — the Food and Drug Administration admitting, for instance, that the vaccines killed numerous children — a coalition of medical organizations is fighting to legally force the government to keep recommending the COVID jabs to healthy kids and pregnant women.

That legal effort appears especially questionable given the finding in a recent study that children spared from the vaccine also appear to have been spared from an unfortunate health complication.

'I only feel more vindicated I didn't take the COVID shot.'

The peer-reviewed study — conducted by researchers at the University of Oxford, the University of Bristol, and the Harvard T.H. Chan School of Public Health, and published in January in the scientific journal Epidemiology — looked at the safety and effectiveness of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine in healthy children ages 5-15 following the rollout that began in late 2021.

Using data from the OpenSAFELY-TPP database with the blessing of NHS England, the researchers compared the "effectiveness and safety of: (1) the first vaccine dose versus no vaccination and (2) a second dose versus a single dose only."

Specifically, they compared 141,711 children ages 5-11 and 410,463 adolescents ages 12-15 who were given a first dose of the vaccine with equal numbers of unvaccinated children from the same age groups.

RELATED: 'Rogue' Biden judge blocks critical pieces of RFK Jr.'s vaccine reform

Photographer: Emily Elconin/Bloomberg via Getty Images

The researchers found that the vaccination provided some benefits, including an "initial protective effect" that waned by 14 weeks as well as a lower incidence of emergency room visits than recorded among the unvaccinated cohort.

They noted, however, that "myocarditis and pericarditis were documented only in the vaccinated groups, with rates of 27 and 10 cases/million after the first and second doses, respectively."

As late as January 2023, the U.K. Health Security Agency said that "the reported rate for heart inflammation (myocarditis and pericarditis) was 13 per million first doses and 8 per million second doses of the monovalent Pfizer/BioNTech vaccine" among those under the age of 18.

"That there were no cases of myocarditis or pericarditis in the unvaccinated group does not mean that such events cannot occur without COVID-19 vaccination, only that these events were not observed in the unvaccinated groups in our specific matched analyses," the study noted.

For adolescents, the reduction in risk of COVID-19 hospitalization following vaccination was larger than the corresponding increase in risk of both myocarditis and pericarditis, said the researchers. The same could not, however, be said of younger children.

"The reduction in risk of COVID-19 hospitalization in children (−0.02 for first dose vs. unvaccinated) was lower than the increase in risk of pericarditis (0.22)," said the study.

Sen. Rand Paul, the Kentucky Republican who introduced legislation last month that would strip the liability shield from vaccine manufacturers, said in response to the study, "As it stands right now, families are limited as to how they can seek justice due to legal carveouts for COVID-19 vaccine manufacturers."

"We ought to pass my bill, the End the Vaccine Carveouts Act, to hold pharma accountable properly," added Paul.

Turning Point USA contributor Riley Gaines said, "As more time passes, I only feel more vindicated I didn't take the COVID shot. I feel sorry for the people who did."

Last year, the FDA required Pfizer and Moderna to start noting the estimated unadjusted incidence of heart conditions following administration of the 2023-2024 formula of the BNT162b2 and Spikevax vaccines as well as the longitudinal results of a 2024 study concerning cardiac manifestations and outcomes of vaccine-associated myocarditis in American youths.

H/T Evie Magazine

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

'Rogue' Biden judge blocks critical pieces of RFK Jr.'s vaccine reform



A federal judge appointed by former President Joe Biden obliged medical establishmentarians on Monday, blocking three critical elements of the Trump administration's vaccine reform.

Brian Murphy — a Boston-based U.S. district court judge who previously barred the Trump administration from swiftly deporting illegal aliens — paused Health and Human Services Secretary Robert F. Kennedy Jr.'s reconstitution of the Advisory Committee on Immunization Practices, the federal panel whose vaccine recommendations become official policy at the Centers for Disease Control and Prevention.

'How much embarrassment can this Judge take?'

In addition to freezing out Kennedy's ACIP appointees prior to their planned discussion of COVID-19 vaccines this week, Murphy also halted the health secretary's reform of the child vaccination schedule as well as Kennedy's May 2025 directive rescinding the recommendation that pregnant women and healthy kids get the COVID vaccine.

The shake-up

As of early 2025, all 17 members of the ACIP were Biden appointees.

Some of the members were brazen partisans. Oliver Brooks, for instance, made a habit of donating to Democrat candidates, including failed presidential candidate Kamala Harris, and called for research to be "intentionally antiracist." Noel Brewer, a 2020 Biden donor, similarly demonstrated a DEI-lensed preoccupation with race.

Most members had collected small fortunes in consulting fees and research support from some of the very pharmaceutical giants whose products the panel had recommended, prompting questions about the members' loyalties and commitment to public health.

RELATED: FDA finally admits COVID-19 vaccine killed kids: 'This is a profound revelation'

JOSEPH PREZIOSO/AFP via Getty Images

Kennedy noted in a June 9 article, "The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine."

"It has never recommended against a vaccine — even those later withdrawn for safety reasons," continued Kennedy. "It has failed to scrutinize vaccine products given to babies and pregnant women. To make matters worse, the groups that inform ACIP meet behind closed doors, violating the legal and ethical principle of transparency crucial to maintaining public trust."

On June 10, Kennedy announced that he had canned all 17 members of the ACIP, accused the panel of "malevolent malpractice," and vowed to appoint "highly credentialed physicians and scientists who will make extremely consequential public health determinations by applying evidence-based decision-making with objectivity and common sense."

Medical establishmentarians melted down over the removal of the Biden holdovers.

Susan Kressly, who was the president of the American Academy of Pediatrics at the time, said, "We are witnessing an escalating effort by the administration to silence independent medical expertise and stoke distrust in lifesaving vaccines."

Their fury was compounded when Kennedy announced whom he was appointing to the newly vacant panel — experts such as Dr. Robert Malone, an early pioneer in messenger RNA technology, and Dr. Cody Meissner, a professor of pediatrics at the Geisel School of Medicine at Dartmouth who ruffled feathers in 2021 by criticizing ruinous mask mandates for children.

In January, the Trump administration dealt those clinging to the status quo another upset, modifying the childhood immunization schedule.

RELATED: The Conspiracy Instinct

Photo by Kevin Dietsch/Getty Images

Whereas previously, the CDC recommended that kids get vaccines for 18 diseases — loading them up with twice as many doses as their European counterparts — the Trump administration reduced its list of vaccination recommendations for all children to jabs for the following 11 diseases: diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type B, pneumococcal conjugate, polio, measles, mumps, rubella, human papillomavirus, and chickenpox.

The lawsuit

The American Academy of Pediatrics and other medical groups sued the administration in July over its termination of COVID vaccine recommendations for healthy kids and pregnant women, then amended their complaint to incorporate challenges to the ACIP shake-up and changes to the immunization schedule updates.

'We will keep appealing these lawless decisions.'

Judge Murphy echoed the plaintiffs' talking points in his ruling on Monday and said, "There is a method to how these decisions [about which vaccines to make available through insurers and government programs] historically have been made — a method scientific in nature and codified into law through procedural requirements. Unfortunately, the Government has disregarded those methods and thereby undermined the integrity of its actions."

Murphy questioned the qualifications held by the majority of current ACIP members but spared his fellow Biden appointees who previously served on the panel from such scrutiny.

He also said that the ACIP, as currently staffed, violates Congress' requirement that such committees "be fairly balanced."

Murphy, opting for stays over injunctions, stayed Kennedy's appointments of new ACIP members, all votes taken by the new ACIP members, and the January changes to the childhood immunization schedule.

The response

The medical groups behind the lawsuit celebrated Murphy's ruling.

Andrew Racine, president of the AAP, called it "a historic and welcome outcome for children, communities, and pediatricians everywhere."

"This decision effectively means that a science-based process for developing immunization recommendations is not to be trifled with and represents a critical step to restoring scientific decision-making to federal vaccine policy that has kept children healthy for years," added Racine.

"Today's ruling is a win for public health and reaffirms that national vaccine policy should be guided by rigorous, evidence-based science, not politics," said Jason Goldman, president of the American College of Physicians. "Scientific consensus and overwhelming evidence demonstrate that vaccines are safe and effective."

The HHS said that it will appeal the ruling.

"We look forward to this judge’s decision being overturned just like his other attempts to keep the Trump administration from governing," wrote HHS spokesman Andrew Nixon.

Deputy Attorney General Todd Blanche noted, "We will keep appealing these lawless decisions, and we will keep winning. The question is, how much embarrassment can this Judge take?"

Dr. Robert Malone said that the "rogue judge" had "inserted himself between the elected executive branch and its constitutional authority to govern."

Malone, who faced years of abuse for questioning the safety of mRNA vaccines and the severity of COVID-19, emphasized that "the political timing of this ruling is impossible to ignore" and that "the practical consequences of Monday's ruling are serious."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

'Hold Big Pharma accountable': Vaxx giants are sure to be nervous about Rand Paul's new bill



Vaccine manufacturers such as Pfizer made record profits pushing experimental drugs during the pandemic that were nowhere near as "safe and effective" as marketed.

Although their vaccines allegedly left some Americans badly injured and allegedly killed others, Big Pharma giants were largely protected from civil lawsuits as the result of special liability protections that were repeatedly extended by the Biden administration.

'When it comes to vaccines, and in many cases the COVID vaccine, the rules are rigged.'

Republican Sen. Rand Paul (Ky.) introduced legislation last week that would amend the Public Health Service Act to strip the liability shield from vaccine manufacturers.

"If a drug hurts someone, you can sue the company in court," said Paul, a licensed doctor of medicine. "You can hold them responsible through the normal legal process. But when it comes to vaccines, and in many cases the COVID vaccine, the rules are rigged: You're funneled into a federal no-fault program that limits damages, restricts your options, and — in many cases — leaves people without real justice. That's cronyism."

Presently, persons seeking compensation for injuries sustained as the result of a covered vaccine must file a petition with the National Vaccine Injury Compensation Program, which is touted as a "no-fault alternative to the traditional legal system for resolving vaccine injury petitions."

Those specifically injured by one of the experimental COVID-19 vaccines — which were in many jurisdictions required to remain employed, eat in public, stay in school, or visit loved ones — must file a petition with the related Countermeasures Injury Compensation Program.

RELATED: Finally: Vaccine guidelines that make sense for parents

Photo by Kevin Dietsch/Getty Images

Parents, legal guardians, and legal representatives of those individuals who were killed by the vaccines — the U.S. Food and Drug Administration admitted in December that "at least 10 children have died after and because of receiving COVID-19 vaccination" — can file on behalf of the decedents.

The catch is that suffering an injury or dying around the time of the receipt of a COVID jab "is not sufficient, by itself, to prove that an injury is the direct result of a covered countermeasure."

Since there is a high bar for proving causation, few Americans' petitions are successful.

'Pharma giants are hiding behind legal protections to avoid being sued.'

CICP data shows that as of Feb. 1, a total of 14,102 COVID-19 claims have been filed, 10,944 alleging injuries or death from COVID-19 vaccines and 3,158 alleging injuries or death from other COVID-19 countermeasures.

Of the total, 6,556 were rejected outright. Of the 6,649 for which decisions were made, only 93 claims were found eligible for compensation — and of the 93, only 44 petitioners have actually received compensation.

Sen. Paul's End the Vaccine Carveout Act, which was co-sponsored by Sen. Mike Lee (R-Utah) and serves as a companion bill to the legislation of the same name introduced in the House in July by Rep. Paul Gosar (R-Ariz.), would reform the Vaccine Injury Compensation Program by allowing vaccine-injured individuals or the legal representatives of those killed by vaccines to pursue direct civil action in state or federal court without having to first try their chances at the no-fault federal system.

Presently, vaccine-injured Americans are generally required to file a petition through VICP before seeking judicial relief. The Republican bill would eliminate that barrier to possible justice.

The bill would also exclude COVID-19 vaccines from the definition of "covered countermeasures," thereby ending the immunity shield that has for years protected vaccine manufacturers, distributors, and administration from vaccine injury claims.

Lee stated, "Pharma giants are hiding behind legal protections to avoid being sued by Americans experiencing serious vaccine side effects."

"Many of these patients were forced to get vaccinated or lose their jobs during the pandemic and are now dealing with permanent and very serious complications," Lee continued. "Our bill will end these unconstitutional vaccine carveouts so that all Americans can receive the justice they deserve and hold Big Pharma accountable."

Weeks after the 2024 presidential election, former Health and Human Services Secretary Xavier Becerra extended the liability shield for COVID-19 vaccine manufacturers through Dec. 31, 2029.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Here’s The Good, The Bad, And The Ugly Of The White House Health Plan

The White House's 'Great Health Care Plan' contains some good policies and some not-so-good ones.

FDA finally admits COVID-19 vaccine killed kids: 'This is a profound revelation'



Millions of Americans across the country were told during the pandemic to offer up their arms for the COVID-19 vaccines — the first-ever mRNA vaccines approved by the U.S. Food and Drug Administration — if they wanted to keep their jobs, eat in public, stay in school, or visit their loved ones.

Government officials, the establishment media, and pharmaceutical representatives claimed that the vaccines were "safe and effective." Those who dared to suggest otherwise about the experimental drugs that were making liability-shielded vaccine manufacturers record profits were often attacked and censored.

Months after the Department of Health and Human Services concluded that "mRNA technology poses more risks than benefits for these respiratory viruses," the Food and Drug Administration admitted in an internal letter that the COVID-19 vaccines killed numerous children.

'Healthy young children who faced tremendously low risk of death were coerced.'

Dr. Vinay Prasad, chief medical officer at the FDA and director at the Center for Biologics Evaluation and Research, noted in an email to staff on Friday that FDA Office of Biostatistics and Pharmacovigilance career staff "have found that at least 10 children have died after and because of receiving COVID-19 vaccination."

In the email, which was reviewed by multiple publications and shared online by the Washington Post, Prasad indicated that the OBPV performed an analysis of 96 deaths between 2021 and 2024 and concluded "that no fewer than 10 are related. If anything, this represents conservative coding, where vaccines are exculpated rather than indicated in cases of ambiguity. The real number is higher."

"These deaths are related to vaccination (likely/probable/possible attribution made by staff). That number is certainly an underestimate due to underreporting, and inherent bias in attribution," wrote Prasad. "This safety signal has far-reaching implications for Americans, the U.S. pandemic response, and the agency itself."

RELATED: Pfizer COVID shot sales plummet after Trump administration ends universal recommendations

Photo by SAUL LOEB/AFP via Getty Images

Despite the strong improbability of a healthy child getting seriously ill from COVID, former National Institute of Allergy and Infectious Diseases Director Anthony Fauci, former Centers for Disease Control and Prevention Director Rochelle Walensky, and other health officials championed injecting kids with the novel vaccines.

On Nov. 2, 2021, then-President Joe Biden's health officials gave final approval to Pfizer's COVID-19 shot for kids ages 5 to 11. Biden said at the time, "It is a major step forward for our nation in our fight to defeat the virus."

COVID-19 vaccination for children younger than 5 began across the U.S. in June 2022.

"These vaccines are safe, highly effective, and will give parents the peace of mind of knowing their child is protected from the worst outcomes of COVID-19," said Biden.

Prasad noted in his Friday letter that despite evidence that the COVID-19 vaccine put boys and young men at great risk of myocarditis, Biden health officials "did not quickly attempt mitigation strategies such as spacing doses apart, lowering doses, omitting doses among those with prior COVID-19."

Myocarditis is inflammation of the heart muscle that can manifest as various symptoms, including heart palpitations, chest pain, fainting, and weakness, and can also cause fatal cardiac arrest.

"Worse, the FDA delayed acknowledgement of the safety signal until after it could extend marketing authorization to younger boys 12-15," continued Prasad. "Had the acknowledgement come early, these younger boys, who likely did not require COVID-19 vaccination, may have chosen to avoid the products."

The FDA's chief medical officer stressed that the OBPV's finding that the COVID vaccine contributed to the deaths of children amounted to "a profound revelation."

"For the first time, the U.S. FDA will acknowledge that COVID-19 vaccines have killed American children," continued Prasad, whose agency revoked emergency-use authorization for COVID vaccines earlier this year. "Healthy young children who faced tremendously low risk of death were coerced, at the behest of the Biden administration, via school and work mandates, to receive a vaccine that could result in death. In many cases, such mandates were harmful."

Peter Marks, Prasad's predecessor, complained to the New York Times about the "political tone" of Prasad's letter and noted, "I would not be surprised if the attributions turn out to be debatable, as these cases are often quite complex."

FDA commissioner Dr. Marty Makary said in a "Fox & Friends" interview on Saturday that his agency would no longer "rubber-stamp things with no data," adding that such a "mockery of science" was alternatively "the M.O. in the Biden administration with the eternal COVID booster approvals for young, healthy kids."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Why Trump’s Obesity Drug ‘Deal’ Will Help Big Pharma Most Of All

With the market for GLP-1s already exploding, Americans might be best served by a government that focuses on promoting competition to drive down prices.

Do you really have ADHD — or do they want to medicate you into conformity?



Everybody has a diagnosis these days.

Not just adults — kids too. It doesn’t matter if you're 8 or 38, there's someone somewhere waiting to explain away whatever's different about you.

Perhaps you find your work excruciatingly boring and hard to care about precisely because it is excruciatingly boring and hard to care about.

It's not a quirk of your personality or a flaw in your character or a wound in your soul. It's a illness. Never mind that the symptoms are vague or the evidence that it's a discrete medical condition are lacking — a pharmaceutical cure will fix it.

Just pop this pill, and you will be like everyone else. Isn’t that what you want?

All the rage

All the kids these days have ADHD or autism. Which often makes me wonder if any of them do. Or if these conditions exist at all.

Autism certainly seems real in its extreme forms, but I am not at all convinced that it's at the far end of a continuum. I don’t really think being a little “on the spectrum” is a thing. Those people are just a little weird and need stronger guidance on how to get on in life.

I have a friend who was an engineer at Google. He told me half the people he worked with claimed to be “on the spectrum,” and according to him, it was all bull. They didn’t have medical problems; they had personal problems. They were guys who never learned how to interact normally, so they just ended up being kind of weird and rude.

As for ADHD, it's so obscenely overdiagnosed that it's essentially fake at this point. The market has been so oversaturated by ridiculous and erroneous diagnoses that whenever I hear about another kid with ADHD, it tells me more about the doctors and the “system” and less about the kid.

Boys will be boys

Are some kids better at sitting down at a desk for three hours at a time? Sure. Are more girls than boys better at doing it? Yes. Is there a gender factor here when it comes to diagnosis? Absolutely.

Boys don’t learn the same way girls do. But much of modern education ignores this fact. So when boys fidget or get bored, it gets chalked up to ADHD. This is more or less common knowledge by now. So the only thing a boy being diagnosed with ADHD tells me is that he doesn't get enough recess.

Of course, there are extreme cases. There are kids who genuinely don’t seem to be able to focus at all. Something like actual ADHD exists in a small number of boys, but that doesn't negate the broader truth: Instead of seeing people as individuals with different strengths and weaknesses, we decide to overmedicate when someone isn’t exactly like everyone else.

My mom worked with special ed kids. Some of them had mild disabilities, some more extreme. In some cases, it was clear they would need supervised care their entire lives. But in other cases, it wasn't clear just what, if anything, was wrong — besides a certain learned helplessness reinforced by doctors and parents.

Pill and chill

Nowadays ADHD diagnoses aren’t just for kids; adults are getting in on it too. Believe it or not, an increasing amount of men and women, especially women, in their 30s and 40s are discovering that they too have ADHD — a discovery that inevitably “explains everything.” My wife sees reels on Instagram all the time, along with ads selling various solutions.

What's that? You couldn’t focus at your computer, clicking on an excel spreadsheet, sending pointless emails for seven hours at a time? Shocking. No, you don’t need ADHD medication. You need to do something else with your life. Perhaps you find your work excruciatingly boring and hard to care about precisely because it is excruciatingly boring and hard to care about.

Overmedicalization and overdiagnosis is a deep problem in our society. Not just because the result is an increase in prescription drug use, but because the individual human being is lost or suffocated a little bit at a time. Everyone is different. Everyone has skills, and everyone has weaknesses. Everyone learns in a different way, and everyone focuses on different things too.

RELATED: Drugged for being boys: The TRUTH behind the ADHD scam

Blaze Media

Free agency

Some people are just a little awkward, a little weird, a little absent-minded, or a little dry. Sure, they should try to meet society halfway in some reasonable sense — but that happens through early teaching, parental guidance, community expectations, and personal effort, not through a pill you pop every day. For most of the 20th century, we relied far more on those nonmedical supports.

All the pill-popping flattens our individualism and undercuts our own agency as humans. It presupposes that one cannot make oneself better, one cannot work to act right, and that one doesn’t have any control. This is a lie. Yes, of course, there are people who suffer with truly debilitating problems who need medication, and they should get that medication. But it is a small fraction of the population. Most people can make themselves better when they set their minds to it.

Don’t get me wrong. I'm not anti-psychiatry. I'm not into alternative medicine or any of the hippie stuff. I’m not denying that there are people with problems who are helped most effectively with medication. I’m thankful for the blessings of modern medicine and the advancements we continue to see every year.

But we have a problem with overdiagnosis in our country. We have a problem with losing sight of the individual. We have a problem with people who want to give up their agency and turn it all over to a pill, and we are worse off because of it.

Trump strikes major deal with pharma giants Lilly and Novo over obesity drugs, Medicare



Health and Human Services Secretary Robert F. Kennedy Jr. is working on identifying and tackling the root causes of America's obesity epidemic. In the meantime, the Trump administration wants to make sure that Americans have access to affordable diabetes and weight-loss drugs, specifically glucagon-like peptide-1 receptor agonists, better known as GLP-1 drugs.

To this end and as part of his months-long campaign to bring most-favored-nation prescription drug pricing to Americans, President Donald Trump has struck a deal with pharmaceutical giants Eli Lilly and Novo Nordisk, the manufacturer of Ozempic, to cut prices on their weight-loss drugs in exchange for Medicare coverage.

A senior administration official indicated on Thursday that since Trump issued his most-favored-nation pricing executive order in May, GLP-1 drugs "have been top of mind" — not just because of the pharmaceuticals' apparent cardiometabolic benefits "but also because this is, again, an issue of fairness."

RELATED: How MAHA can really save American lives

IM WATSON/AFP via Getty Images

Per the terms of Trump's deal with the two companies, "starting oral doses of GLP-1s will cost just $149 for everyone on Medicare, Medicaid, or Trump Rx," said an official. "That's roughly 1/9th of today's list price."

For Medicare, the manufacturers have reportedly agreed to reduce prices on GLP-1 drugs that are currently used for diabetes and other covered conditions to $245 per month across all other doses, added the official.

Savings generated by these price reductions will apparently be used to provide new coverage for GLP-1 drugs to patients struggling with obesity who face high metabolic or cardiovascular risk at the same monthly cost of $245.

As of 2020, over 100 million American adults were obese, and more than 22 million adults suffered from severe obesity, according to the Centers for Disease Control and Prevention.

While the adult obesity rate reportedly declined from 39.9% in 2022 to 37% this year — representing roughly 7.6 million fewer obese adults — Gallup recently indicated that diagnoses of diabetes have reached an all-time high of 13.8%.

Amid the glut of diabetes cases, there has been a significant increase in the number of U.S. adults who report taking GLP-1 drugs — from 5.8% in February 2024 to 12.4% in the latest quarter of 2025. The three-year decline in obesity among most age groups appears to correspond with the embrace of the weight-loss drugs.

When asked roughly how many patients on Medicare and Medicaid would be impacted by these changes, another administration official noted that in Medicare, around 10% of the population will be eligible for the standard access. While the drugs are approved for a much broader population, access has been constrained for "patients that will benefit clinically from it."

There will reportedly be three tiers of patients in Medicare who will have access to these drugs for the purposes of addressing obesity and driving "cardiometabolic improvement": those with a body mass index greater than 27 kg/m² suffering from pre-diabetes or established cardiovascular disease; patients with a BMI greater than 30 who have uncontrolled hypertension, kidney disease, and/or heart failure; and individuals with a BMI exceeding 35.

'We do not believe that GLP-1s or drugs alone are somehow some silver bullet.'

"This is about making America healthy again," said the second official. "This is about preventing strokes, this is about preventing heart attacks, and this is about preventing end-stage renal disease."

The officials acknowledged, however, that cheaper drugs do not amount to a long-term solution to the problem of obesity.

"Make no mistake: We're in a war against obesity. We do not believe that GLP-1s or drugs alone are somehow some silver bullet to make the ... country healthy again," said one official. "They are an important jump-start."

In exchange for their cooperation, the pharma giants are gaining additional access to beneficiaries who wouldn't otherwise be covered by Medicare for obesity indications, certainty from the Trump administration on its approach to drug pricing moving forward, and a commitment to invest in American manufacturing.

One Trump administration official told reporters that this initiative is expected to ultimately be cost neutral, stating, "This is really a win-win on all sides — for taxpayers, for Medicare beneficiaries, as well as for the companies."

Last month, Trump announced an agreement with AstraZeneca that would guarantee every state Medicaid program across the country most-favored-nation drug prices on the pharma giant's products. The previous month, he announced a similar deal with Pfizer.

"In case after case, our citizens pay massively higher prices than other nations pay for the same exact pill, from the same factory, effectively subsidizing socialism [abroad] with skyrocketing prices at home," Trump said in a statement. "So we would spend tremendous amounts of money in order to provide inexpensive drugs to another country. And when I say the price is different, you can see some examples where the price is beyond anything — four times, five times different."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Tylenol fights autism claims, slams proposed FDA warning label as 'unsupported' by science



The maker of Tylenol is fighting back against proposed changes to its label.

Kenvue, the American company behind Tylenol, says changes proposed by a recent petition would be "improper."

'Fight like hell not to take it.'

After the Trump administration linked the use of Tylenol during pregnancy to autism, the Informed Consent Action Network urged the FDA to "change the labels" for Tylenol and provide "crucial warnings for pregnant women and their care providers."

No evidence for risk?

Kenvue responded directly to the petition in its own document and said that changing the labeling to its over-the-counter acetaminophen products in such a manner would be "unsupported by the scientific evidence and legally and procedurally improper."

Requesting that the consumer-facing warning addresses a risk between "acetaminophen use and neurodevelopmental disorders" would allegedly go against the "overwhelming weight of the evidence contradicts the existence of any such risk," Kenvue claimed.

The manufacturer called acetaminophen one of the "most studied medicines in history," with evidence regarding its use during pregnancy being "continuously evaluated by the FDA for more than a decade."

It further claimed that available evidence does not support "a causal association between acetaminophen use in pregnancy and neurodevelopmental disorders, including ASD and ADHD."

RELATED: Tylenol's concerns about possible autism risk date back more than a decade, documents reportedly show

Billion-dollar brand

CNN reported that Tylenol generates about $1 billion annually for Kenvue and is considered to be its top-selling brand.

If the FDA agrees with ICAN's demand, Tylenol labels would need to be updated from its current instructions that say, "If pregnant or breast-feeding, ask a health professional before use."

President Trump had previously said during a press conference in September that if used during pregnancy, Tylenol was linked to a "very increased risk of autism."

"Fight like hell not to take it," Trump added.

RELATED: 'TrumpRx' website to offer discounted drugs as part of landmark Big Pharma deal

Photo by Jordan Bank/NWSL via Getty Images

New autism drug

At the same time, the U.S. Food and Drug Administration had begun its process to approve a treatment for autism-related symptoms.

The FDA announced in late September that it had approved leucovorin calcium tablets for patients with "cerebral folate deficiency."

The neurological condition affects folate transfer into the brain, the FDA said, adding that "individuals with cerebral folate deficiency have been observed to have developmental delays with autistic features."

"We have witnessed a tragic four-fold increase in autism over two decades," said FDA Commissioner Marty Makary. "Children are suffering and deserve access to potential treatments that have shown promise. We are using gold standard science and common sense to deliver for the American people."

According to the Mayo Clinic, leucovorin has a few side effects, all of which are listed as rare. These include skin rash, hives or itching, and wheezing. "Convulsions (seizures)" are also listed.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Trump launches 'TrumpRx' to slash drug prices — and even brings Pfizer on board



President Trump announced earlier this week his effort aimed at lowering drug costs, which includes the creation of a “TrumpRx” website, where Americans can buy medicine at a discount — and somehow got Pfizer to agree to join him.

“The United States is done subsidizing the health care of the rest of the world,” Trump said. “By taking this bold step, we’re ending the era of global price gouging at the expense of American families.”

Surprisingly, Pfizer is the first pharmaceutical company to comply with Trump’s demands, which include selling drugs to Medicaid and setting prices of new drugs at “Most-Favored Nation” levels, which is the lowest price available in other countries.

BlazeTV host Stu Burguiere is surprised by the move.


“This is interesting to me for a bunch of different reasons,” Burguiere tells BlazeTV host Dave Landau. “First of all, as a conservative, I don’t really like the idea of the government being involved in these things, but there are, you know, real concerns with drug prices on certain things.”

“The other thing I find fascinating about it, is like a big chunk of Donald Trump’s base thinks Pfizer is the Nazi regime. Literally hates this company more than anything else. And what I find fascinating about it is Trump can just do this stuff,” he continues.

“He’s the only guy I’ve ever seen that can just do this stuff. He can embrace a company that his base hates and somehow just go right down the middle unscathed,” he adds.

Want more from Stu?

To enjoy more of Stu's lethal wit, wisdom, and mockery, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.